Media-OutReach Newswire A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Media-OutReach Newswire CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Media-OutReach Newswire HKBU unveils treatment potential of herbal extract compound isoliquiritigenin for pancreatic cancer
Media-OutReach Newswire HKBU unveils treatment potential of herbal extract compound isoliquiritigenin for pancreatic cancer
Media-OutReach Newswire Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Media-OutReach Newswire SMART launches new research group M3S to advance AI, automation and the future of work
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire Fosun Participates in the 3rd BEYOND Expo to Deepen Biotechnology Innovation and Global Development
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
Media-OutReach Newswire Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
Media-OutReach Newswire IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV
Media-OutReach Newswire Led by Legend Capital, GenScript ProBio Completed Nearly USD220m Series C Round of Financing
French, VN defence ministers agree to promote cooperation to level commensurate with Strategic Partnership 3.
Low rate of adverse reactions from AstraZeneca COVID shots in Việt Nam, immunisation official says 4.